As of Dec 02
| -0.16 / -0.98%|
The 3 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 20.00, with a high estimate of 20.00 and a low estimate of 19.00. The median estimate represents a +23.23% increase from the last price of 16.23.
The current consensus among 3 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.